IMCC

IMCC

Im Cannabis Corp

IM Cannabis Corp breeds and grows medical cannabis, supplying dried flowers and extracts to medical patients in Israel and Germany. It operates retail pharmacies, distribution centers, and online platforms to deliver quality-controlled products.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ CAD
$1,000 invested 5 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-3.47%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-15.09%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth34.07%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth36.48%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth59.19%
Net Trend33%
Net Income Consistency
Rev Growth192.47%
Rev Trend67%
Revenue Consistency

See the full market ranking โ†’

Im Cannabis Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 15M to $ 54M and net income went from -$ 28M to -$ 11M. Revenue increased in 3 of those 5 years; net income in 1.

Im Cannabis Corp currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.13โ€”
1 Year2025-08-12
$ 2.60-95.00%
5 Years2021-08-12
$ 298.80-99.96%
All Time2020-05-20
$ 118.56-99.89%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 46M-$ 11M$ 1M
2025$ 54M-$ 11M$ 2M
2024$ 54M-$ 10M$ 863K
2023$ 48M-$ 9M$ 1M
2022$ 54M-$ 188M$ 2M
2021$ 34M-$ 17M$ 13M
IPO2020$ 15M-$ 28M$ 8M

Explore beyond IMCC

You're looking at Im Cannabis Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies